Domain Parters Vii L P - Net Worth and Insider Trading
Domain Parters Vii L P Net Worth
The estimated net worth of Domain Parters Vii L P is at least $45 Million dollars as of 2024-11-13. Domain Parters Vii L P is the 10% Owner of Zogenix Inc and owns about 810,254 shares of Zogenix Inc (ZGNX) stock worth over $22 Million. Domain Parters Vii L P is the 10% Owner of Tobira Therapeutics Inc and owns about 394,813 shares of Tobira Therapeutics Inc (TBRA) stock worth over $17 Million. Domain Parters Vii L P is also the 10% Owner of Esperion Therapeutics Inc and owns about 2,566,935 shares of Esperion Therapeutics Inc (ESPR) stock worth over $6 Million. Besides these, Domain Parters Vii L P also holds Obalon Therapeutics Inc (OBLN) , Clovis Oncology Inc (CLVSQ) , Evoke Pharma Inc (EVOK) , Orexigen Therapeutics Inc (OREXQ) . Details can be seen in Domain Parters Vii L P's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Domain Parters Vii L P has not made any transactions after 2019-08-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Domain Parters Vii L P
Domain Parters Vii L P Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Domain Parters Vii L P owns 11 companies in total, including Obalon Therapeutics Inc (OBLN) , Regado Biosciences Inc (RGDO) , and Evoke Pharma Inc (EVOK) among others .
Click here to see the complete history of Domain Parters Vii L P’s form 4 insider trades.
Insider Ownership Summary of Domain Parters Vii L P
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| OBLN | Obalon Therapeutics Inc | 2019-08-06 | 10 percent owner |
| RGDO | Regado Biosciences Inc | 2016-11-01 | 10 percent owner |
| EVOK | Evoke Pharma Inc | 2016-05-26 | 10 percent owner |
 | | 2014-10-21 | 10 percent owner |
| | 2014-11-19 | 10 percent owner |
| | 2014-03-17 | 10 percent owner |
| | 2013-11-13 | 10 percent owner |
| | 2013-06-04 | 10 percent owner |
| | 2011-12-22 | 10 percent owner |
| | 2011-09-16 | 10 percent owner |
| | 2016-10-05 | 10 percent owner |
Domain Parters Vii L P Latest Holdings Summary
Domain Parters Vii L P currently owns a total of 7 stocks. Among these stocks, Domain Parters Vii L P owns 810,254 shares of Zogenix Inc (ZGNX) as of November 29, 2010, with a value of $22 Million and a weighting of 47.64%. Domain Parters Vii L P owns 394,813 shares of Tobira Therapeutics Inc (TBRA) as of May 4, 2015, with a value of $17 Million and a weighting of 36.62%. Domain Parters Vii L P also owns 2,566,935 shares of Esperion Therapeutics Inc (ESPR) as of October 21, 2014, with a value of $6 Million and a weighting of 13.78%. The other 4 stocks Obalon Therapeutics Inc (OBLN) , Clovis Oncology Inc (CLVSQ) , Evoke Pharma Inc (EVOK) , Orexigen Therapeutics Inc (OREXQ) have a combined weighting of 1.96% among all his current holdings.
Latest Holdings of Domain Parters Vii L P
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ZGNX | Zogenix Inc | 2010-11-29 | 810,254 | 26.68 | 21,617,577 |
| TBRA | Tobira Therapeutics Inc | 2015-05-04 | 394,813 | 42.09 | 16,617,679 |
| ESPR | Esperion Therapeutics Inc | 2014-10-21 | 2,566,935 | 2.44 | 6,250,487 |
| OBLN | Obalon Therapeutics Inc | 2019-08-06 | 271,144 | 3.05 | 826,989 |
| CLVSQ | Clovis Oncology Inc | 2013-06-04 | 2,581,745 | 0.02 | 38,726 |
| EVOK | Evoke Pharma Inc | 2016-05-26 | 4,210 | 5.00 | 21,050 |
| OREXQ | Orexigen Therapeutics Inc | 2011-12-22 | 296,742 | 0.01 | 1,573 |
Holding Weightings of Domain Parters Vii L P
Domain Parters Vii L P Form 4 Trading Tracker
According to the SEC Form 4 filings, Domain Parters Vii L P has made a total of 0 transactions in Zogenix Inc (ZGNX) over the past 5 years. The most-recent trade in Zogenix Inc is the acquisition of 288,824 shares on November 29, 2010, which cost Domain Parters Vii L P around $9 Million.
According to the SEC Form 4 filings, Domain Parters Vii L P has made a total of 0 transactions in Tobira Therapeutics Inc (TBRA) over the past 5 years. The most-recent trade in Tobira Therapeutics Inc is the acquisition of 30,864 shares on May 4, 2015, which cost Domain Parters Vii L P around $3 Million.
According to the SEC Form 4 filings, Domain Parters Vii L P has made a total of 0 transactions in Esperion Therapeutics Inc (ESPR) over the past 5 years. The most-recent trade in Esperion Therapeutics Inc is the acquisition of 500,000 shares on October 21, 2014, which cost Domain Parters Vii L P around $10 Million.
More details on Domain Parters Vii L P's insider transactions can be found in the Insider Trading History of Domain Parters Vii L P table.Insider Trading History of Domain Parters Vii L P
- 1
Domain Parters Vii L P Trading Performance
GuruFocus tracks the stock performance after each of Domain Parters Vii L P's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Domain Parters Vii L P is 13.05%. GuruFocus also compares Domain Parters Vii L P's trading performance to market benchmark return within the same time period. The performance of stocks bought by Domain Parters Vii L P within 3 months outperforms 5 times out of 21 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Domain Parters Vii L P's insider trading performs compared to the benchmark.
Performance of Domain Parters Vii L P
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 13.7 | | | | | |
| Relative Return to S&P 500(%) | 9.85 | | | | | |
Domain Parters Vii L P Ownership Network
Ownership Network List of Domain Parters Vii L P
Ownership Network Relation of Domain Parters Vii L P
Domain Parters Vii L P Owned Company Details
What does Obalon Therapeutics Inc do?
Who are the key executives at Obalon Therapeutics Inc?
Domain Parters Vii L P is the 10 percent owner of Obalon Therapeutics Inc. Other key executives at Obalon Therapeutics Inc include director & President & CEO & Exec Chairman Andrew P Rasdal , Chief Financial Officer Nooshin Hussainy , and Chief Technology Officer Mark Brister .
Obalon Therapeutics Inc (OBLN) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Obalon Therapeutics Inc (OBLN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Obalon Therapeutics Inc (OBLN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Obalon Therapeutics Inc (OBLN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Obalon Therapeutics Inc Insider Transactions
Domain Parters Vii L P Mailing Address
Above is the net worth, insider trading, and ownership report for Domain Parters Vii L P. You might contact Domain Parters Vii L P via mailing address: One Palmer Square Suite 515, Princeton Nj 08542.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
